Kiragen Bio
Pre-clinicalKiraGen Bio engineers multiplex-edited, off-the-shelf CAR-T therapies that block tumor suppression—like noise-cancelling headphones for cancer. Guided by our AI platform, KiraLOGIC, we’re advancing a lead program in glioblastoma and building a blueprint for durable cell therapies across solid tumors.
Founded
2020
Focus
Cell & Gene Therapy
About
KiraGen Bio engineers multiplex-edited, off-the-shelf CAR-T therapies that block tumor suppression—like noise-cancelling headphones for cancer. Guided by our AI platform, KiraLOGIC, we’re advancing a lead program in glioblastoma and building a blueprint for durable cell therapies across solid tumors.
Funding History
2Total raised: $20M
Series A$15MUndisclosedMay 15, 2022
Seed$5MUndisclosedSep 15, 2020
Company Info
TypePrivate
Founded2020
LocationCambridge, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile